Echocardiography in Patients With Covid-19

Official Title

Echocardiography in Patients With Covid-19 Undergoing Intensive Care Therapy

Brief Summary

Prospective observational study of patients treated due to Covid-19 disease. Observation and analysis of echocardiographic studies performed in the intensive care setting.

Status

Withdrawn

Conditions

COVID

ARDS, Human

Eligibility Criteria

Inclusion Criteria:

- Age above 18 years

- Covid-19 disease

- invasive Ventilation

Exclusion Criteria:

- none

Eligibility Gender

All

Eligibility Age

Minimum: 18 Years ~ Maximum: N/A

Countries

Germany

Locations

University Hospital Tubingen
Tubingen, BW, Germany

NCT Number

NCT04412460

MeSH Terms

Respiratory Distress Syndrome

Disclaimer:

Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.

(202) 849 - 2075

1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036

admin@reaganudall.org

University Hospital Tuebingen

Echocardiography in Patients With Covid-19

Disclaimer:

Subscribe for updates from the Reagan-Udall Foundation for the FDA